Weed (BUDZ) Shares Outstanding (2010 - 2026)
Weed (BUDZ) posted quarterly Shares Outstanding (Entity) of $148.3 million for Q1 2026, up 9.11% year-over-year from $135.9 million in Q1 2025, and up 0.6% quarter-over-quarter from $147.4 million in Q4 2025.
Weed (BUDZ) Shares Outstanding (2010 - 2026) Analysis & Trends
Weed's Shares Outstanding (Entity) history runs 13 years deep, the most recent figure standing at $148.3 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 9.11% year-over-year to $148.3 million; the TTM figure through Mar 2026 stood at $148.3 million (up 9.11% YoY), while the FY2025 annual figure was $147.4 million, up 17.54% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $148.3 million, up from $147.4 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $148.3 million in Q1 2026, with the low at $120.8 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $123.5 million (2022), against an average of $128.6 million.
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) changed 0.0% in 2023, then grew 17.54% in 2025.
- Weed's Shares Outstanding (Entity) stood at $123.5 million in 2022, then changed by 0.0% to $123.5 million in 2023, then gained by 1.58% to $125.4 million in 2024, then climbed by 17.54% to $147.4 million in 2025, then gained by 0.6% to $148.3 million in 2026.
- Business Quant data shows BUDZ's Shares Outstanding (Entity) at $148.3 million in Q1 2026, $147.4 million in Q4 2025, and $135.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | Weed | 2.88 Mn | 2.88 Mn | - | 124.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 124.13 Mn |
| Dec 31, 2025 | 124.13 Mn |
| Sep 30, 2025 | 124.13 Mn |
| Jun 30, 2025 | 124.13 Mn |
| Mar 31, 2025 | 124.13 Mn |
| Dec 31, 2024 | 124.13 Mn |
| Sep 30, 2024 | 126.68 Mn |
| Jun 30, 2024 | 126.27 Mn |
| Mar 31, 2024 | 123.81 Mn |
| Dec 31, 2023 | 123.71 Mn |
| Sep 30, 2023 | 123.48 Mn |
| Jun 30, 2023 | 123.48 Mn |
| Mar 31, 2023 | 123.48 Mn |
| Dec 31, 2022 | 122.08 Mn |
| Sep 30, 2022 | 122.94 Mn |
| Jun 30, 2022 | 121.91 Mn |
| Mar 31, 2022 | 119.93 Mn |
| Dec 31, 2021 | 116.73 Mn |
| Sep 30, 2021 | 117.92 Mn |
| Jun 30, 2021 | 116.08 Mn |